0001235802-24-000005.txt : 20240102
0001235802-24-000005.hdr.sgml : 20240102
20240102170518
ACCESSION NUMBER: 0001235802-24-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240102
DATE AS OF CHANGE: 20240102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Semba Charles Pauling
CENTRAL INDEX KEY: 0001872863
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36291
FILM NUMBER: 24503374
MAIL ADDRESS:
STREET 1: TWO CARLSON PARKWAY, SUITE 260
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55447
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc.
CENTRAL INDEX KEY: 0001401040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 CARLSON PARKWAY
STREET 2: SUITE 210
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55305
BUSINESS PHONE: (763) 496-5454
MAIL ADDRESS:
STREET 1: 301 CARLSON PARKWAY
STREET 2: SUITE 210
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55305
FORMER COMPANY:
FORMER CONFORMED NAME: DiaMedica Inc.
DATE OF NAME CHANGE: 20070525
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0508
4
2024-01-02
0
0001401040
DiaMedica Therapeutics Inc.
DMAC
0001872863
Semba Charles Pauling
301 CARLSON PARKWAY, SUITE 210
MINNEAPOLIS
MN
55305
1
0
0
0
0
Voting Common Shares, no par value per share
2024-01-02
4
A
0
9375
2.8
A
39318
D
These shares are issuable upon vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $26,250. The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024.
Includes 9,375 shares issuable on vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan.
/s/ Amy E. Culbert, attorney-in-fact
2024-01-02